Percutaneous radiofrequency ablation for the treatment of early stage hepatocellular carcinoma: A health technology assessment

International Journal of Technology Assessment in Health Care

Volumn 26, Issue 4, 2010, Pages 390-397

  Xie, Xuanqian ^a   Dendukuri, Nandini ^b,c   McGregor, Maurice ^b,c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cost analysis; Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation; Surgical resection

Indexed keywords

COST ANALYSIS; HEPATOCELLULAR CARCINOMA; META-ANALYSIS; RADIO-FREQUENCY ABLATION; SURGICAL RESECTION;

ABLATION; COST ACCOUNTING; COSTS; FISH; HEALTH RISKS; SENSITIVITY ANALYSIS; STIMULATED RAMAN SCATTERING; SURGERY;

COST BENEFIT ANALYSIS;

ARTICLE; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; DATA BASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION; RECURRENCE RISK; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT INDICATION; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 78649980441     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462310001029     Document Type: Article

References (24)

1. Amersi FF, Elrath-Garza A, AhmadA, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg. 2006;141:581-587.
2. Bouza AC, Martin FJ, Magro PMA, et al. Efficacy and safety of radiofrequency ablation of malignant liver tumours: A systematic review.Madrid: Agencia de Evaluacion de Tecnologias Sanitarias (AETS); 2004.
3. Buell JF, Thomas MT, Rudich S, et al. Experience with more than 500 minimally invasive hepatic procedures. Ann Surg. 2008;248:475-486.
4. Chen MS, Li JQ, Liang HH, et al. [Comparison of effects of percutaneous radiofrequency ablation and surgical resection on small hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi. 2005;85:80-83.
5. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321-328.
6. Chen RF, Xiao TH, Zhou QB. [Therapeutic clinical effect of radiofrequency ablation for small hepatocellular carcinoma in cirrhotic patients: A meta-analysis]. Zhonghua Wai Ke Za Zhi. 2008;46:1413-1418.
7. Cho CM, Tak WY, Kweon YO, et al. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma]. Korean J Hepatol. 2005;11:59-71.
8. Cormier JN, Thomas KT, Chari RS, Pinson CW. Management of hepatocellular carcinoma. J Gastrointest Surg. 2006;10:761-780.
9. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: A critical review of the literature. Am J Surg. 2008;195: 508-520.
10. Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2008;12:192-198.
11. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model withinstudy variability. J Clin Epidemiol. 2008;61:41-51.
12. Hasegawa K, Makuuchi M, Takayama T, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594.
13. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005;39:247-252.
14. Khan MR, Poon RT, Ng KK, et al. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg. 2007;142:1136-1143.
15. Kooby DA, Egnatashvili V, Graiser M, et al. Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center. J Surg Oncol. 2008;98:81-88.
16. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review. Ann Surg. 2009;249:20-25.
17. Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol. 2007;10:38-46.
18. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: Radiofrequency ablation or resection? HPB. (Oxford). 2007;9:429-434.
19. Marlow N E, et al. Radiofrequency ablation for the treatment of liver tumours: A systematic review. ASERNIP-S Report No: 56. Adelaide, South Australia: ASERNIP-S; 2006.
20. National Institute for Clinical Excellence. Radiofrequency ablation for the treatment of colorectal metastases in the liver. London: National Institute for Clinical Excellence (NICE); 2004.
21. Pugh RN,Murray-Lyon IM,Dawson JL, Pietroni MC,Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
22. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ. Radiofrequency ablation of liver tumors: A systematic review. Arch Surg. 2006;141:181-190.
23. Takahashi S, Kudo M, Chung H, et al. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25:303-309.
24. Zhai B, Xu AM, Chen Y, Li XY, Liu S, Wu MC. [Radiofrequency ablation for larger hepatocellular carcinomas]. Di Er Jun Yi Da Xue Xue Bao. 2007;28:651-655.